Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Louisa Ziglar, MD, FACR: ‘Everyone Can Be an Advocate’

Leslie Mertz, PhD  |  March 18, 2021

TR: Has the pandemic affected how you advocate for rheumatology?

Dr. Ziglar: There’s a camaraderie and a level of comfort that you can have when you meet legislators and their staff in person. That’s harder to attain when communicating through a screen, but with email, online meetings, Twitter, Facebook and any number of other platforms, we are still getting the word out.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

TR: Who would you encourage to become an advocate?

Dr. Ziglar: Everyone can be an advocate. You don’t have to start right out of a fellowship. Like me, you can be someone who has been in the clinic for many years, finally have the kids out of their diapers and have extra time to feed your desire to speak up about injustices or problems that you see from day to day. One of the fastest and easiest ways to get started is to click on the links in call-for-action emails from the ACR, type in your personal experience and send it. That helps to really magnify and increase the momentum of the issues that we at the GAC want to push through. I also encourage everyone to support RheumPAC, which will likewise champion our causes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

All advocacy is important. The more we stay silent and hold back our opinions, the less likely we are going to be able to help each other as practitioners and also our patients, who rely on us to be their voice.


Leslie Mertz, PhD, is a freelance science journalist based in northern Michigan.

Every ACR/ARP member can advance rheumatology by being an advocate for rheumatology issues, practices and patients. Find tools and resources from the ACR to guide your advocacy journey.

Page: 1 2 | Single Page
Share: 

Filed under:Legislation & AdvocacyProfiles Tagged with:AdvocacyGovernment Affairs Committee (GAC)Louisa Ziglar

Related Articles

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    Telemedicine & Fellowship Education After COVID-19: Q&A with Kanika Monga, MD

    July 14, 2020

    The COVID-19 pandemic is reshaping clinical rheumatology and the fellowship experience. Rheumatology education should include how to triage patients for remote visits, says second-year fellow Kanika Monga, MD…

    The ACR Releases New Telemedicine Position Statement

    July 6, 2020

    The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences